查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1734852

2032年藥用玻璃管市場預測：按玻璃類型、製造流程、形狀、分銷管道、應用、最終用戶和地區進行的全球分析

Pharmaceutical Glass Tubing Market Forecasts to 2032 - Global Analysis By Glass Type (Borosilicate Glass, Soda-Lime Glass, and Other Glass Types), Manufacturing Process, Form, Distribution Channel, Application, End Users and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的預測，全球藥用玻璃管市場規模預計在 2025 年達到 160.9 億美元，到 2032 年將達到 240.4 億美元，預測期內的複合年成長率為 5.9%。

藥用玻璃管是一種用於製造儲存和分配藥品容器的特殊玻璃。它主要由硼矽酸玻璃或鈉鈣玻璃製成，具有很高的耐化學性、熱穩定性和耐用性。這種玻璃透過防止藥物與容器發生相互作用，確保了藥物的純度和安全性。它常用於製藥和生物技術行業，用於製造管瓶、安瓿瓶和注射器。

增加醫療基礎建設投資

對優質醫藥包裝日益成長的需求，推動了全球醫療基礎設施的投資。各國政府和私營機構正致力於改善藥物儲存和輸送系統，以確保安全性和有效性。先進的藥用玻璃管因其卓越的耐化學性和極低的污染風險而備受青睞。玻璃管材料的創新提高了耐用性，並支持高效的給藥方法。此外，慢性病發生率的上升也刺激了改善醫療包裝解決方案的投資。

玻璃脫層風險

玻璃脫層是管瓶內表面薄層剝落的現象，對藥品包裝構成了重大挑戰。這一問題可能會損害藥物穩定性，並導致患者健康風險。製造商必須實施嚴格的品管措施來降低這些風險，但這會增加生產成本。此外，在不同配方中保持一致的玻璃品質也十分複雜，限制市場的發展。

嚴格的藥品安全監理標準

遵守這些標準可實現高品質、無污染的包裝，從而推動對先進玻璃管解決方案的需求。特種塗層和改進的玻璃成分使製藥公司能夠滿足嚴格的安全要求。生技藥品和注射劑的日益成長的關注推動了對可靠耐用玻璃管的需求。那些投資研發以提高產品完整性的公司正在市場上獲得競爭優勢。

有限的回收和永續性挑戰

特種玻璃成分複雜，難以回收，引發環境擔憂。製造商正在探索環保替代品，但成本和技術障礙阻礙了其推廣應用。此外，藥用玻璃廢棄物的處理必須遵循嚴格的規範，這進一步加劇了永續性的複雜性。開發商面臨開發更環保解決方案的壓力，同時需要保持產品功效並符合法規要求。

COVID-19的影響

新冠疫情對藥用玻璃管市場產生了重大影響，既有正面的一面，也有負面的一面。疫苗包裝需求的增加導致玻璃管產量激增，從而推動了市場成長。然而，供應鏈中斷和原料短缺導致生產和分銷延誤。疫情凸顯了可靠的藥品包裝對藥品穩定性和安全性的重要性。自疫情爆發以來，企業一直致力於提高生產效率，以應對未來的醫療危機。

透明管市場預計將成為預測期內最大的市場

由於其透明度和化學穩定性，透明管預計將在預測期內佔據最大的市場佔有率。透明管有助於藥物檢測，確保注射藥物的品管和安全。透明管受到製造商的青睞，因為它們與各種製劑相容，並降低了污染風險。生物製藥和疫苗的日益普及也推動了該領域的需求。

預測期內，醫院和診斷中心部門將見證最高的複合年成長率。

預計醫院和診斷中心細分市場將在預測期內實現最高成長率，這得益於醫療機構和診斷實驗室數量的不斷增加，從而推動了對可靠醫藥包裝解決方案的需求。精準醫療等醫療技術的進步需要高品質的玻璃管用於藥物傳輸。對病人安全和藥物療效的日益關注進一步刺激了該細分市場的需求。此外，醫院擴建和政府醫療保健措施也支持了市場的持續成長。

比最大的地區

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於其強大的醫療基礎設施和不斷成長的藥品產量。中國、印度和日本等國家已成為藥品製造和包裝創新領域的主要參與者。政府鼓勵醫療保健進步的政策正在推動該地區市場的成長。領先的藥用玻璃管製造商的存在提高了供應鏈效率並降低了價格。

複合年成長率最高的地區：

受嚴格的監管標準和技術進步的推動，北美地區預計將在預測期內呈現最高的複合年成長率。生技藥品和注射劑的日益成長的關注推動了對優質玻璃管材料的需求。美國和加拿大的製藥公司正在大力投資創新包裝解決方案，以提高藥物穩定性。不斷成長的醫療保健支出和嚴格的藥品安全要求進一步推動了市場擴張。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球藥用玻璃管市場（以玻璃類型）

  • 硼硼矽酸玻璃（I型）
  • 鈉鈣玻璃（II 型和 III 型）
  • 其他玻璃類型

6. 全球藥用玻璃管市場（依製造流程）

  • 模壓玻璃管
  • 管狀玻璃管

7. 全球藥用玻璃管市場類型

  • 透明管
  • 彩色管
  • 霜管
  • 其他形狀

8. 全球藥用玻璃管市場（依分銷管道）

  • 直銷
  • 經銷商
  • 線上管道

第9章全球藥用玻璃管市場（按應用）

  • 管瓶
  • 安瓿
  • 墨水匣
  • 注射器
  • 試管
  • 瓶子
  • 其他用途

第10章 全球藥用玻璃管市場（依最終用戶）

  • 製藥商
  • 契約製造組織（CMO）
  • 生技公司
  • 醫院和診斷中心
  • 研發實驗室
  • 其他最終用戶

第11章全球藥用玻璃管市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Schott AG
  • Gerresheimer AG
  • Nipro Corporation
  • SGD Pharma
  • Stevanato Group SpA
  • West Pharmaceutical Services, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Ardagh Group SA
  • Bormioli Pharma SpA
  • Piramal Glass Private Limited
  • Shandong Weigao Group Medical Polymer Products Co., Ltd.
  • Nihon Yamamura Glass Co., Ltd.
  • Amino GmbH
  • Richland Glass Company, Inc.
Product Code: SMRC29489

According to Stratistics MRC, the Global Pharmaceutical Glass Tubing Market is accounted for $16.09 billion in 2025 and is expected to reach $24.04 billion by 2032 growing at a CAGR of 5.9% during the forecast period. Pharmaceutical glass tubing is a specialized type of glass used in the production of containers for storing and delivering medications. Made primarily from borosilicate or soda-lime glass, it offers high chemical resistance, thermal stability, and durability. This glass ensures the purity and safety of pharmaceutical products by preventing interactions with the container. It is commonly used to manufacture vials, ampoules, and syringes in the pharmaceutical and biotechnology industries.

Market Dynamics:

Driver:

Rising investment in healthcare infrastructure

The increasing demand for high-quality pharmaceutical packaging is driving investment in healthcare infrastructure globally. Governments and private entities are focusing on improving drug storage and delivery systems to ensure safety and efficacy. Advanced pharmaceutical glass tubing provides superior chemical resistance and minimizes contamination risks, making it a preferred choice. Technological innovations in tubing materials enhance durability and support efficient drug administration methods. Additionally, the rising prevalence of chronic diseases is fuelling investments in improved medical packaging solutions.

Restraint:

Risk of glass delamination

Glass delamination, a phenomenon where thin layers peel away from the internal surface of a vial, poses a significant challenge to pharmaceutical packaging. This issue can lead to compromised drug stability and potential health risks for patients. Manufacturers must implement rigorous quality control measures to mitigate these risks, increasing production costs. Additionally, the complexity of maintaining consistent glass quality across different formulations adds to the restraint in market expansion.

Opportunity:

Stringent regulatory standards for drug safety

Compliance with these standards ensures high-quality, contamination-free packaging driving demand for advanced glass tubing solutions. Specialized coatings and improved glass compositions help pharmaceutical companies meet stringent safety requirements. As the focus on biologics and injectable drugs grows, the need for reliable and durable glass tubing rises. Companies investing in research and development to enhance product integrity are gaining a competitive edge in the market.

Threat:

Limited recycling and sustainability challenges

The complex composition of specialty glass makes recycling difficult, leading to environmental concerns. Manufacturers are exploring eco-friendly alternatives, but adoption remains slow due to cost and technical barriers. Additionally, the disposal of pharmaceutical glass waste must adhere to strict guidelines, further complicating sustainability efforts. Companies are under pressure to develop greener solutions while maintaining product efficacy and regulatory compliance.

Covid-19 Impact

The COVID-19 pandemic significantly influenced the pharmaceutical glass tubing market, both positively and negatively. Increased demand for vaccine packaging led to a surge in glass tubing production, boosting market growth. However, supply chain disruptions and raw material shortages caused delays in manufacturing and distribution. The pandemic underscored the importance of reliable pharmaceutical packaging for drug stability and safety. Companies have since focused on enhancing production efficiency to meet future healthcare crises.

The clear tubing segment is expected to be the largest during the forecast period

The clear tubing segment is expected to account for the largest market share during the forecast period, due to its transparency and chemical stability. Clear tubing facilitates easy drug inspection, ensuring quality control and safety for injectable medicines. Manufacturers prefer clear tubing for its compatibility with various formulations, reducing contamination risks. The growing adoption of biologic drugs and vaccines is further propelling demand for this segment.

The hospital & diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospital & diagnostic centers segment is predicted to witness the highest growth rate, due to the increasing number of healthcare facilities and diagnostic labs is driving the need for reliable drug packaging solutions. Advancements in medical treatments, including precision therapies, require high-quality glass tubing for drug delivery. The emphasis on patient safety and drug efficacy further strengthens demand within this segment. Additionally, hospital expansions and government healthcare initiatives support sustained market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by robust healthcare infrastructure and rising pharmaceutical production. Countries like China, India, and Japan have established themselves as key players in drug manufacturing and packaging innovation. Government policies promoting healthcare advancements are fuelling market growth across the region. The presence of leading pharmaceutical glass tubing manufacturers enhances supply chain efficiency and affordability.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, propelled by strict regulatory standards and technological advancements. The growing focus on biologics and injectable drugs is driving demand for superior glass tubing materials. Pharmaceutical companies in the U.S. and Canada are heavily investing in innovative packaging solutions to enhance drug stability. Rising healthcare expenditure and stringent drug safety requirements further accelerate market expansion.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Tubing Market include Schott AG, Gerresheimer AG, Nipro Corporation, SGD Pharma, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., Corning Incorporated, DWK Life Sciences GmbH, Ardagh Group S.A., Bormioli Pharma S.p.A., Piramal Glass Private Limited, Shandong Weigao Group Medical Polymer Products Co., Ltd., Nihon Yamamura Glass Co., Ltd., Amino GmbH, and Richland Glass Company, Inc.

Key Developments:

In May 2025, SCHOTT Pharma, announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in its joint venture SCHOTT Poonawalla from Serum Institute of India (SII). SCHOTT Poonawalla is a joint venture of SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group and a global leader in vaccine manufacturing, dedicated to providing affordable vaccines worldwide.

In November 2024, SGD Pharma expands capacity of siliconized glass vials with the announcement of a new siliconization line at its Center of Excellence for Type I glass in France. The company enhances its already extensive range of in-house services by internalizing its glass siliconization offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.

Glass Types Covered:

  • Borosilicate Glass (Type I)
  • Soda-Lime Glass (Types II & III)
  • Other Glass Types

Manufacturing Processes Covered:

  • Molded Glass Tubing
  • Tubular Glass Tubing

Forms Covered:

  • Clear Tubing
  • Colored Tubing
  • Frosted Tubing
  • Other Forms

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Channels

Applications Covered:

  • Vials
  • Ampoules
  • Cartridges
  • Syringes
  • Test Tubes
  • Bottles
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Hospital & Diagnostic Centers
  • Research & Development Labs
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Tubing Market, By Glass Type

  • 5.1 Introduction
  • 5.2 Borosilicate Glass (Type I)
  • 5.3 Soda-Lime Glass (Types II & III)
  • 5.4 Other Glass Types

6 Global Pharmaceutical Glass Tubing Market, By Manufacturing Process

  • 6.1 Introduction
  • 6.2 Molded Glass Tubing
  • 6.3 Tubular Glass Tubing

7 Global Pharmaceutical Glass Tubing Market, By Form

  • 7.1 Introduction
  • 7.2 Clear Tubing
  • 7.3 Colored Tubing
  • 7.4 Frosted Tubing
  • 7.5 Other Forms

8 Global Pharmaceutical Glass Tubing Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors
  • 8.4 Online Channels

9 Global Pharmaceutical Glass Tubing Market, By Application

  • 9.1 Introduction
  • 9.2 Vials
  • 9.3 Ampoules
  • 9.4 Cartridges
  • 9.5 Syringes
  • 9.6 Test Tubes
  • 9.7 Bottles
  • 9.8 Other Applications

10 Global Pharmaceutical Glass Tubing Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Contract Manufacturing Organizations (CMOs)
  • 10.4 Biotechnology Companies
  • 10.5 Hospital & Diagnostic Centers
  • 10.6 Research & Development Labs
  • 10.7 Other End Users

11 Global Pharmaceutical Glass Tubing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Schott AG
  • 13.2 Gerresheimer AG
  • 13.3 Nipro Corporation
  • 13.4 SGD Pharma
  • 13.5 Stevanato Group S.p.A.
  • 13.6 West Pharmaceutical Services, Inc.
  • 13.7 Corning Incorporated
  • 13.8 DWK Life Sciences GmbH
  • 13.9 Ardagh Group S.A.
  • 13.10 Bormioli Pharma S.p.A.
  • 13.11 Piramal Glass Private Limited
  • 13.12 Shandong Weigao Group Medical Polymer Products Co., Ltd.
  • 13.13 Nihon Yamamura Glass Co., Ltd.
  • 13.14 Amino GmbH
  • 13.15 Richland Glass Company, Inc.

List of Tables

  • Table 1 Global Pharmaceutical Glass Tubing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Pharmaceutical Glass Tubing Market Outlook, By Glass Type (2024-2032) ($MN)
  • Table 3 Global Pharmaceutical Glass Tubing Market Outlook, By Borosilicate Glass (Type I) (2024-2032) ($MN)
  • Table 4 Global Pharmaceutical Glass Tubing Market Outlook, By Soda-Lime Glass (Types II & III) (2024-2032) ($MN)
  • Table 5 Global Pharmaceutical Glass Tubing Market Outlook, By Other Glass Types (2024-2032) ($MN)
  • Table 6 Global Pharmaceutical Glass Tubing Market Outlook, By Manufacturing Process (2024-2032) ($MN)
  • Table 7 Global Pharmaceutical Glass Tubing Market Outlook, By Molded Glass Tubing (2024-2032) ($MN)
  • Table 8 Global Pharmaceutical Glass Tubing Market Outlook, By Tubular Glass Tubing (2024-2032) ($MN)
  • Table 9 Global Pharmaceutical Glass Tubing Market Outlook, By Form (2024-2032) ($MN)
  • Table 10 Global Pharmaceutical Glass Tubing Market Outlook, By Clear Tubing (2024-2032) ($MN)
  • Table 11 Global Pharmaceutical Glass Tubing Market Outlook, By Colored Tubing (2024-2032) ($MN)
  • Table 12 Global Pharmaceutical Glass Tubing Market Outlook, By Frosted Tubing (2024-2032) ($MN)
  • Table 13 Global Pharmaceutical Glass Tubing Market Outlook, By Other Forms (2024-2032) ($MN)
  • Table 14 Global Pharmaceutical Glass Tubing Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 15 Global Pharmaceutical Glass Tubing Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 16 Global Pharmaceutical Glass Tubing Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 17 Global Pharmaceutical Glass Tubing Market Outlook, By Online Channels (2024-2032) ($MN)
  • Table 18 Global Pharmaceutical Glass Tubing Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Pharmaceutical Glass Tubing Market Outlook, By Vials (2024-2032) ($MN)
  • Table 20 Global Pharmaceutical Glass Tubing Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 21 Global Pharmaceutical Glass Tubing Market Outlook, By Cartridges (2024-2032) ($MN)
  • Table 22 Global Pharmaceutical Glass Tubing Market Outlook, By Syringes (2024-2032) ($MN)
  • Table 23 Global Pharmaceutical Glass Tubing Market Outlook, By Test Tubes (2024-2032) ($MN)
  • Table 24 Global Pharmaceutical Glass Tubing Market Outlook, By Bottles (2024-2032) ($MN)
  • Table 25 Global Pharmaceutical Glass Tubing Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Pharmaceutical Glass Tubing Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Pharmaceutical Glass Tubing Market Outlook, By Pharmaceutical Manufacturers (2024-2032) ($MN)
  • Table 28 Global Pharmaceutical Glass Tubing Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 29 Global Pharmaceutical Glass Tubing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
  • Table 30 Global Pharmaceutical Glass Tubing Market Outlook, By Hospital & Diagnostic Centers (2024-2032) ($MN)
  • Table 31 Global Pharmaceutical Glass Tubing Market Outlook, By Research & Development Labs (2024-2032) ($MN)
  • Table 32 Global Pharmaceutical Glass Tubing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.